GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Feb 2012 04:45 PM
RNS
Director/PDMR Shareholding
10 Feb 2012 12:38 PM
RNS
Director/PDMR Shareholding
10 Feb 2012 12:32 PM
RNS
Director/PDMR Shareholding
09 Feb 2012 05:18 PM
RNS
Transaction in Own Shares
08 Feb 2012 05:59 PM
RNS
Transaction in Own Shares
08 Feb 2012 03:51 PM
RNS
Director/PDMR Shareholding
07 Feb 2012 02:20 PM
RNS
Director/PDMR Shareholding
07 Feb 2012 12:00 PM
RNS
Final Results
06 Feb 2012 05:38 PM
RNS
Director/PDMR Shareholding
03 Feb 2012 06:04 PM
RNS
Replacement Director/PDMR Shareholding
03 Feb 2012 04:59 PM
RNS
Replacement Director/PDMR Shareholding
01 Feb 2012 03:11 PM
RNS
Director/PDMR Shareholding
01 Feb 2012 01:55 PM
RNS
Total Voting Rights
31 Jan 2012 04:39 PM
RNS
Director/PDMR Shareholding
27 Jan 2012 10:59 AM
RNS
GSK announces changes to its Board
23 Jan 2012 06:03 PM
RNS
Director/PDMR Shareholding
20 Jan 2012 09:56 AM
RNS
Additional Listing
19 Jan 2012 06:18 PM
RNS
Director/PDMR Shareholding
17 Jan 2012 02:05 PM
RNS
Director/PDMR Shareholding
16 Jan 2012 04:47 PM
RNS
Director/PDMR Shareholding
13 Jan 2012 06:08 PM
RNS
Director/PDMR Shareholding
13 Jan 2012 06:05 PM
RNS
Director/PDMR Shareholding
12 Jan 2012 04:04 PM
RNS
Director/PDMR Shareholding
12 Jan 2012 04:00 PM
RNS
Director/PDMR Shareholding
12 Jan 2012 03:57 PM
RNS
Director/PDMR Shareholding
10 Jan 2012 06:32 PM
RNS
Director/PDMR Shareholding - Replacement
10 Jan 2012 06:22 PM
RNS
Director/PDMR Shareholding - Replacement
10 Jan 2012 05:51 PM
RNS
Director/PDMR Shareholding
10 Jan 2012 05:47 PM
RNS
Director/PDMR Shareholding
10 Jan 2012 05:44 PM
RNS
Director/PDMR Shareholding
10 Jan 2012 05:41 PM
RNS
Director/PDMR Shareholding
10 Jan 2012 05:38 PM
RNS
Director/PDMR Shareholding
09 Jan 2012 06:27 PM
RNS
Director/PDMR Shareholding
09 Jan 2012 06:00 PM
RNS
Director/PDMR Shareholding
09 Jan 2012 04:43 PM
RNS
Director/PDMR Shareholding
09 Jan 2012 12:51 PM
RNS
Director/PDMR Shareholding
09 Jan 2012 07:01 AM
RNS
Initial outcomes of Phase III studies for Relovair
06 Jan 2012 04:35 PM
RNS
Director/PDMR Shareholding
06 Jan 2012 04:32 PM
RNS
Director/PDMR Shareholding
06 Jan 2012 04:29 PM
RNS
Director/PDMR Shareholding
03 Jan 2012 05:30 PM
RNS
Director/PDMR Shareholding
03 Jan 2012 04:17 PM
RNS
Total Voting Rights
03 Jan 2012 03:50 PM
RNS
Director/PDMR Shareholding
03 Jan 2012 12:30 PM
RNS
Director/PDMR Shareholding
22 Dec 2011 03:00 PM
RNS
Director/PDMR Shareholding
22 Dec 2011 10:43 AM
RNS
Director/PDMR Shareholding
21 Dec 2011 06:15 PM
RNS
Director/PDMR Shareholding
21 Dec 2011 06:10 PM
RNS
Director/PDMR Shareholding
20 Dec 2011 05:02 PM
RNS
Director/PDMR Shareholding
20 Dec 2011 01:15 PM
RNS
Update on divestment of non-core OTC brands

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings